BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11817153)

  • 21. Oculo-respiratory syndrome in association with the influenza vaccine: Canada, October-November 2000.
    Can Commun Dis Rep; 2000 Dec; 26(23):201-2. PubMed ID: 11149349
    [No Abstract]   [Full Text] [Related]  

  • 22. Statement on influenza vaccination for the 1993-94 season. The National Advisory Committee on Immunization.
    CMAJ; 1993 Sep; 149(5):647-51, 654-8. PubMed ID: 8364821
    [No Abstract]   [Full Text] [Related]  

  • 23. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1990-1991 season.
    Can Dis Wkly Rep; 1990 Jun; 16(25):117-21. PubMed ID: 2397526
    [No Abstract]   [Full Text] [Related]  

  • 24. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 25. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1994-95 season.
    Can Commun Dis Rep; 1994 Jun; 20(11):85-92. PubMed ID: 7522728
    [No Abstract]   [Full Text] [Related]  

  • 26. Addendum. National Advisory Committee on Immunization (NACI) Statement on influenza vaccination for the 2007-2008 season.
    Can Commun Dis Rep; 2007 Nov; 33(11):23-4. PubMed ID: 18163241
    [No Abstract]   [Full Text] [Related]  

  • 27. Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 Jun; 32(ACS-7):1-27. PubMed ID: 16805064
    [No Abstract]   [Full Text] [Related]  

  • 28. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
    Cooper C; Thorne A;
    Vaccine; 2011 Oct; 29(45):7876-7. PubMed ID: 21872629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination.
    Fredette MJ; De Serres G; Malenfant M
    Clin Infect Dis; 2003 Oct; 37(8):1136-8. PubMed ID: 14523781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():12-8. PubMed ID: 10927838
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Jun; 31(ACS-6):1-30. PubMed ID: 15959943
    [No Abstract]   [Full Text] [Related]  

  • 33. Statement on influenza vaccination for the 1995-96 season. National Advisory Committee on Immunization.
    CMAJ; 1995 Sep; 153(5):591-604. PubMed ID: 7641158
    [No Abstract]   [Full Text] [Related]  

  • 34. Low risk of recurrence of oculorespiratory syndrome following influenza revaccination.
    Skowronski DM; Strauss B; Kendall P; Duval B; De Serres G
    CMAJ; 2002 Oct; 167(8):853-8. PubMed ID: 12406942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 36. Statement on influenza vaccination for the 2001-2002 season.
    National Advisory Committee on Immunization (NACI), Health Canada
    Can Commun Dis Rep; 2001 Aug; 27():1-24. PubMed ID: 11501350
    [No Abstract]   [Full Text] [Related]  

  • 37. Influenza vaccination for the 1984-85 season. National Advisory Committee on Immunization.
    Can Med Assoc J; 1984 Aug; 131(4):304-5. PubMed ID: 6744176
    [No Abstract]   [Full Text] [Related]  

  • 38. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-1):1-12. PubMed ID: 12728646
    [No Abstract]   [Full Text] [Related]  

  • 39. Oculorespiratory syndrome after influenza immunization in children.
    Skowronski DM; Bjornson G; Husain E; Metzger DL; Scheifele DW
    Pediatr Infect Dis J; 2005 Jan; 24(1):63-9. PubMed ID: 15665712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine.
    De Serres G; Boulianne N; Duval B; Rochette L; Grenier JL; Roussel R; Donaldson D; Tremblay M; Toth E; Ménard S; Landry M; Robert Y
    Vaccine; 2003 Jun; 21(19-20):2346-53. PubMed ID: 12744865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.